Hall of Fame Rest&ENT New lost $8.72 per diluted share in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a loss of $9.60 per diluted share. The table below carries 7 fiscal years, from 2018 to 2024, and the quarters Hall of Fame Rest&ENT New has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Hall of Fame Rest&ENT New lost $8.72 per diluted share in fiscal year 2024.
Hall of Fame Rest&ENT New (HOFV) reported a loss of $11.97 per diluted share in fiscal year 2023 and a loss of $8.72 per diluted share in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Hall of Fame Rest&ENT New (HOFV) reported a loss of $9.60 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
Across the 7 fiscal years this page covers, Hall of Fame Rest&ENT New (HOFV) diluted earnings per share went from -$0.12 in fiscal year 2018 to -$8.72 in fiscal year 2024.
Hall of Fame Rest&ENT New (HOFV) reported -$2.18 in diluted earnings per share in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Hall of Fame Rest&ENT New (HOFV) reported on that line in every period on record.
